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Background: Chronic inﬂammation, the fundamental pathogenetic process of atherosclerosis, can bemodiﬁed by
pharmacological and non-pharmacologicalmeasures as a part of secondary prevention after acutemyocardial in-
farction (AMI). The aim of our study was to determine the effect of diet, rich with natural antioxidants, added to
physical activity (as a part of cardiac rehabilitation (CR) program) on inﬂammatorymarkers and ox-LDL, amark-
er of oxidative stress, closely involved in the process of chronic inﬂammation.
Methods: 41 male patients after AMI undergoing CR were divided into a diet group (supervised cardioprotective
diet throughout the CR), and control group (CRwithout diet).Wemeasured hsCRP, leucocytes, neutrophils, IL-6,
oxLDL, exercise capacity and classic risk factors before and after CR program.
Results: Patients from the diet group presentedwith a signiﬁcant decline in classic risk factors (BMI,waist circum-
ference, waist to hip ratio, systolic blood pressure, heart rate, blood glucose, total cholesterol, LDL, TAG) and in-
ﬂammatory markers (hsCRP, leucocytes, neutrophils) compared to control group. Furthermore, when studying
nonsmokers, we observed signiﬁcant decline of oxLDL in the diet group.
Conclusions: The addition of cardioprotective diet, richwith natural antioxidants, to physical activity as a part of a
CR program, positively modiﬁes not just classic risk factors and exercise capacity, but also diminishes chronic in-
ﬂammation markers. These effects, and oxLDL decline were most prominent in nonsmoking patients.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Acute myocardial infarction (AMI) is a common manifestation of
atherosclerotic coronary artery disease (CAD), which is one of the
most important causes of mortality in the developed world [1,2].
Although improvedmanagement has signiﬁcantly lowered CADmortal-
ity [3], we are constantly searching for new strategies to inﬂuence the
cardinal pathological process of atherosclerosis; to diminish inﬂamma-
tion [4]. On the contrary, oxidized low density lipoprotein (oxLDL), aD, coronary artery disease; CR,
, high density lipoprotein; TAG,
d LDL; IL-6, interleukin 6; BMI,
1535910 (Mobile).
d Ltd. This is an open access article unuseful marker of coronary artery disease [5], exhibits a marked
inﬂuence on chronic inﬂammation, since it stimulates the release of
chemotactic factors, cytokines and growth factors from artery wall
cells, which play an important role in the development and progression
of atherosclerotic plaque [6]. Furthermore, it was shown in vivo that
host response to infection and inﬂammation itself induces LDL
oxidation [7], so not only oxLDL stimulates inﬂammation but also the
opposite happens. This conﬁrms the existence of a strong connection
between inﬂammatory response and oxLDL.
Regarding pharmacological therapy, statins and acetylsalicylic
acid have already been proven to effectively reduce low-grade in-
ﬂammation in AMI survivors [8–10] and also to protect LDL against
oxidation [11,12]. Non-pharmacological measures such as physical
activity and diet are also gaining recognition as non-classic risk
factor modiﬁers. Physical activity is associated with diminished
inﬂammation in adults with or without CAD, independently ofder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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protective diet also improves survival in patients after AMI [15,16].
In addition, it has been shown that diet can also reduce the degree
of inﬂammatory markers such as hsCRP and IL-6, not only in patients
with developed coronary heart disease [17], but also in healthy
adults at high risk for developing CAD [18]. Whereas many research
works have proven favorable effects of coupled diet and physical
exercise on inﬂammation in adults with high risk for CAD [19,20],
we did not ﬁnd any studies describing the effects of cardioprotective
diet added to exercise training in patients after acute AMI (fully
developed CAD).
The aim of our study was to explore how the addition of a
cardioprotective diet (richwith natural antioxidants) to physical activity,
which is as an integral part of a rehabilitation program, inﬂuences not
just exercise capacity and classic risk factors for CAD, but also inﬂamma-
tory markers including high sensitivity C-reactive protein (hsCRP),
interleukin-6 (IL-6) and oxLDL. The secondary aim of the study was in-
troduced subsequently since the results were less pronounced as we ex-
pected at the commencement of the study. In search of confounding
factors that could inﬂuence inﬂammation and oxidationmarkers we fur-
ther divided the patients into smoker and nonsmoker groups.
2. Materials and methods
2.1. Patients
Forty-onemale patients with themedian age of 59 years (minimum
36 years, maximum 73 years), discharged from the hospital at least 2
and not more than 9 weeks after AMI were included in our study.
Patients were successively recruited from the standard short-term
(two-week) cardiac rehabilitation (CR) program. In Slovenia the nation-
al insurance company funds such CR programs for all patients after AMI.
Their aims are to improve patients' physical performance and educate
them about prevention of further disease progression, emphasizing
the importance of drug therapy and lifestyle changes. The exercise
program is supervised and all patients participate in lectures about
healthy, cardioprotective diet, however they are allowed to choose
their meals by themselves.
All patients after AMI were optimally treated according to current
guidelines [2]. All patients were receiving acetylsalicylic acid 100 mg
daily (combined with clopidogrel in 9 patients, prasugrel in 18 or
ticagrelor in 13 patients for a year after AMI), angiotensin-converting-
enzyme inhibitors or angiotensin receptor blockers and statins. All pa-
tients were treated with appropriate statin doses (31 of them were re-
ceiving rosuvastatin, 9 atorvastatin and one simvastatin), so that the
target values recommended by ECS were met. All but three patients
were taking beta-blockers and one patient was on ivabradine. The pa-
tient group consisted of 21 smokers and 20 nonsmokers. We deﬁned
nonsmokers as patients who never smoked or stopped smoking at
least a year before AMI occurred (most of them had quit smoking
many years before AMI occurred).
After we acquired informed consent each patient was sorted to
either a diet (21 patients, 10 nonsmokers and 11 smokers) or a control
group of patients (20 patients, 10 nonsmokers and 10 smokers). The pa-
tients from the diet group consumed cardioprotective diet rich with
natural antioxidants throughout the CR, individually prepared by a clin-
ical dietitian (explained in detail in the chapter Diet). All patients were
advised to immediately report to us about possible side effects of the
diet, and all the patients had the right to cease from the study at any
time due personal or other reasons (such as allergic reactions and
changes in digestion).
To minimize the inﬂuence of smoking and statin treatment on the
effects of diet intervention during CR, we sorted out the patients to
the diet or the control group according to smoking status and treatment
with statins. In that way, we obtained groups which did not differ in
percentage of smokers (p = 0.78) and were also balanced regardingstatin doses (no statistically signiﬁcant differences were seen in equiva-
lent statin doses between diets and controls, p = 0.380). Patients from
the diet group proved to be signiﬁcantly younger than patients included
in the control group (52 vs 62.5 years, p = 0.013), what can be ex-
plained by highermotivation of younger patients, who agreed to partic-
ipate in the intervention group.
Exclusion criteria for the studied group were: female gender,
symptoms, signs and laboratory indications of acute infection, known
diseases with ongoing chronic inﬂammation, and daily intake of dietary
supplements and/or vitamins, AMI treated with urgent coronary bypass
surgery, complications of AMI involving the need for urgent surgical in-
tervention and other larger surgical procedures needed during hospital-
ization in the coronary unit.
The study was approved by the Slovenian Board for Medical Ethics
No. 159/06/10 and all subjects gave their written informed consent.
2.2. Study design
2.2.1. CR protocol
The CR programwas carried out in a local health resort. The rehabil-
itation comprised a fourteen-day long, gradual training regimen in ac-
cordance with the Position paper from the Cardiac Rehabilitation
Section of the European Association of Cardiovascular Rehabilitation
and Prevention [21]. The program consisted of supervised physical ac-
tivity, which included daily interval ergometric training (25–30 min),
during which we gradually increased the load with intervals of low in-
tensity (25–40 W) workout inbetween. Patients also participated in
daily stretching and respiratory exercises (30 min), exercises in the
pool (15min) and nordic walk (60min). Stress relief program including
massages and baths was also at patients' disposal. All patients took part
in the educational program, which provided information about the im-
portance of pharmacological therapy, changes in lifestyle and healthy
diet, since mandatory cardioprotective diet is usually not a part of CR
programs in Slovenia.
2.2.2. Cardiac stress testing
We performed a cardiac stress test on a stationary exercise bicycle
ergometer (cycloergometry) for each patient before entering and at
the end of CR program. During the cycloergometry, we raised the load
for 25 W every 3 min. The testing was terminated when the patients
reached the sub-maximal value for their heart rate (85% of themaximal
heart rate), complained of dyspnea or pain (in the chest or other parts of
the body), due to exhaustion, if we found ischemic changes in the ECG,
bundle branch block, hypertensive reaction or if arrhythmias appeared.
Almost all patients from our study had undergone exercise testing al-
ready before the discharge from the hospital or during previous course
of the disease, thus at the inclusion to CR the exercise testing could not
be effected by learning bias.
2.2.3. Cardioprotective diet rich on natural antioxidants
Of all 41 patients, 21 were included in the diet group. They agreed
and were highly motivated to strictly follow diet recommendations
and not to eat anything else but the food advised and supervised by a
clinical dietitian, which was individually prepared for them. The diet
groupwas initially larger but during the course of study 6 patients with-
draw: 2 because of acute enterocolitis, 1 because of acute gout attack,
one because of adverse reactions of the diet (digestion problems and al-
lergic reactions to nuts) and 2 because of personal reasons. None of the
patients from control groupwithdrew from the study. Each patient from
the diet group had ameetingwith a clinical dietitian, who assembled an
individual menu according to patient's weight, body composition,
presence of diabetes and personal preferences. Since we wanted to
compose a cardioprotective diet, which would include our national
healthy foods, we not only balanced the diet according to caloric intake
and percentage of macronutrients, but also enriched it with 300 g of ap-
ples and 30 g of raw nuts daily from integrated, high quality Slovenian
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harvest and are traditionally eaten throughout the year either raw or
in traditional Slovenian pastries. Furthermore, they are among the
most inexpensive fruits. Apples and walnuts were provided for this
study by our colleagues from Biotechnical University, who have
conﬁrmed in previous trials that both apples and walnuts are rich
source of antioxidants and that the apples do not importantly lose anti-
oxidant potential during shelf life [22,23]. The dietitian calculated the
total amount of desired caloric intake for each individual patient, with
the aim to target his or her ideal weight. The majority of patients were
on a reduction diet with a daily intake of approximately 1800 kcal.
The percentage of macronutrients depended on individual needs, but
in general the diet was composed of 25% fat, 60% carbohydrates and
15% proteins. Patients with diabetes had a lower percentage of carbohy-
drates and higher percentage of proteins.
Breakfast, lunch and dinner were served speciﬁcally for the individ-
ual patient, considering the dietitian's recommendations. Two unpeeled
apples and nuts were consumed as snacks between meals.
2.3. Clinical parameters
Clinical examination, measurements of blood pressure (RR), body
weight, height, waist and hip circumference, calculation of body mass
index (BMI), waist to hip ratio and blood sampling were performed
for each patient before and at the end of the CR program. All measure-
ments were carried out in the morning, in the fasting state, data from
both groups were collected in the same time of the year.
2.4. Specimen characteristics
Blood samples were drawn from the antecubital vein of patients in
the morning, after 15 min of rest before entering and at the end of CR
program.
Laboratory tests for complete blood count, glucose, lipids and hsCRP
were performed on the day of the blood collection. For other tests per-
formed later on, plasma or serumwas stored immediately after retrieval
at−70 °C.
2.4.1. Assay methods
The metabolic variables: fasting glucose, triglycerides, total choles-
terol, high-density lipoprotein (HDL) cholesterol and low-density lipo-
protein (LDL) cholesterol were determined from serum by routine
biochemical methods (all Cobas, Roche, Germany). Leucocytes were
determined from whole blood by an automated analyzer (Sysmex,
Clin Lab Products, USA).
HsCRP was determined using polystyrene particles coated with
monoclonal antibodies speciﬁc to human CRP (Siemens, CardioPhase
hsCRP). In this procedure, the sample is mixed with the coated particles
and these aggregates scatter a beam of light passed through the sample.
The result is evaluated by comparison with a standard known concen-
tration [24,25].
Interleukin 6 (IL-6) was quantitatively determined by enzyme im-
munoassay method for the quantitative determination of human IL-6
in serum, plasma and cell culture supernatants (Interleukin-6 ELISA®,
Hamburg, Germany). In this method anti-human IL-6 coating antibody
is adsorbed onto microwells and human IL-6 binds to the antibodies
on the microwells. Biotin-conjugated anti-human IL-6 antibody is
added, which attaches to the human IL-6. Following incubation, un-
bound anti-human IL-6 antibody is removed by a wash step and
Streptavidin HRP is added, which binds to the biotin conjugated anti-
human IL-6 antibody and consequently a colored product is formed in
proportion to the amount of human IL-6 present in the sample. The re-
action is terminated by addition of acid and absorbance is measured at
450 nm.
We used Mercodia Oxidized LDL ELISA for the determination of
oxLDL, which is a solid phase two-side enzyme immunoassay. Twomonoclonal antibodies are directed against separate antigenic determi-
nants on the oxLDL apolipoprotein Bmolecule. During incubation oxLDL
reacts with antibodies bound to microtitration well and after washing
anti-human apolipoprotein B recognizes oxLDL and the bound conju-
gate is detected by reaction with 3,3′,5,5′-tetramethylbenzidine
(TMB). The reaction is stopped by adding acid to give colorimetric end-
point, which is then read spectrophotometrically. Thismethod has been
used in many preceding studies [26].
2.5. Statistical analysis methods
Considering that the distribution was not normal, we used non-
parametrical tests for statistical analysis. Our data is presented as
medians with ranges between the ﬁrst and the third quartile for contin-
uous variables and as numbers and percentages for categorical vari-
ables. Differences in data in independent samples were compared
using the Mann–Whitney U test. Differences in medians of measured
variables before and after the CRprogram in thewhole group of patients
were calculated using the Wilcoxon's rank-sum test for continuous
measures. Depending on the number of cases included in the analysis,
the χ2 or Fisher exact test was used for comparison of differences for
discrete variables. Non-parametric Spearman's correlation coefﬁcients
were calculated to test associations between inﬂammatory and other
parameters. To check the impact of smoking on these results, the
whole group of patients was divided into smokers (N = 20) and non-
smokers (N = 21). Differences in measured variables before and after
the CR program between the subgroups of smokers and nonsmokers
were determined using Wilcoxon's rank-sum test for continuous
measures and Fisher's exact test for categorical variables. Differences
between the group of smokers and nonsmokers were then compared
using the Mann–Whitney U test.
The signiﬁcant effectswere indicatedwhen the p valuewas less than
0.05. We used the SPSS statistic program version 16.0 for statistic
analysis and the graphic presentation of data.
3. Results
3.1. Comparison of exercise capacity, classic risk factors, inﬂammatory
markers and oxLDL between the diet group and the control group of
patients before and after CR
We conﬁrmed that no signiﬁcant differences in exercise testing,
classic risk factors, and inﬂammatorymarkerswere present at the inclu-
sion to the study (before CR) between the diet group and the control
group of patients (Table 1).
During CR we observed important and comparable improvement of
exercise capacity in both the diet group and the control group of
patients. Signiﬁcant decline in classic risk factors including all measured
parameters of metabolic syndrome, except HDL, was however observed
only in the diet group. Such beneﬁts were absent in the control group.
No signiﬁcant changes in inﬂammatory markers were observed in the
control group of patients in contrast to the diet group of patients,
where we demonstrated a decline in leucocytes, neutrophils and
hsCRP, but no signiﬁcant decline of IL-6. No signiﬁcant decline in
ox-LDLwas observed in either the diet group or the control group of pa-
tients (Table 1).
3.2. Comparison of inﬂammatorymarkers and oxLDL between smokers and
nonsmokers in the diet group and the control group of patients before and
after CR
We found signiﬁcant decline of hsCRP, leucocytes and neutrophils
during CR in nonsmoking diets, and a trend towards the decline of
hsCRP in smoking diets. On the other hand, differences between pre-
and post-CR values of hsCRP in nonsmoking and smoking controls
were not signiﬁcant (Table 2A and 2B, Fig. 1). OxLDL signiﬁcantly
Table 1
Exercise testing parameters, classic risk factors and inﬂammation markers in the diet group and the control group of patients after AMI.
Diet group (N = 21) Control group (N = 20)
Before CR (N = 30) After CR Before CR (N = 30) After CR
Maximal systolic BP (mm Hg) 170 (160; 200) 185 (176; 210)⁎ 165 (159; 204) 186 (171; 210)⁎⁎
Maximal HR (bpm) 114 (102; 128) 119 (108; 131)⁎ 112 (104; 118) 118 (108; 129)⁎⁎
Double product (mm Hg ∗ bpm) 20,230 (16,271; 23,898) 22,785 (19,669; 25,860)⁎ 18,450 (14,644; 23,981) 22,489 (17,562; 26,701)⁎⁎,⁎
Maximal load (W) 112 (83; 128) 125 (93; 154)⁎⁎,⁎ 100 (82; 120) 106 (100; 149)⁎⁎,⁎
Maximal load (MET) 5.0 (4.5; 6.2) 5.8 (4.7; 6.9)⁎⁎,⁎ 5.4 (4.6; 5.9) 5.7 (5.4; 6.3)⁎⁎,⁎
Time of load (min) 11.0 (10.0; 13.0) 12.0 (10.0; 14.5)⁎ 10.5 (9.0; 12,8) 12.5 (10.3; 14.0)⁎⁎,⁎
BMI (kg/m2) 29.3 (27.5; 30.9) 28.0 (26.9; 29.8)⁎⁎ 27.5 (25.2; 29.8) 27.5 (25.2; 29.7)
Waist circumference (cm) 102 (98.5; 107.5) 100 (94.5; 104.3)⁎⁎,⁎ 102 (94.3; 109.0) 102 (93.5; 108.5)
Waist/hip ratio 0.98 (0.95; 1.0) 0.97 (0.93; 0.98)⁎⁎ 0.99 (0.90; 1.04) 0.98 (0.91; 1.02)
Resting systolic BP (mm Hg) 130 (121; 140) 120 (110; 130)⁎⁎,⁎ 125 (118; 136) 124 (106; 141)
Resting diastolic BP (mm Hg) 77 (70; 86) 76 (72; 83) 77 (68; 83) 77 (73; 83)
Resting HR (bpm) 68 (63; 77) 61 (59; 68)⁎⁎ 71 (60; 78) 70 (65; 77)
Glucose (mmol/l) 5.2 (4.6; 8.4) 4.6 (4.5; 6.1)⁎⁎,⁎ 4.9 (4.7; 5.8) 5.2 (4.6; 5.7)
Total Cholesterol (mmol/l) 3.2 (3.0; 3.7) 2.9 (2.3; 3.3)⁎⁎ 3.6 (3.0; 4.1) 3.5 (3.1; 3.9)
LDL (mmol/l) 1.8 (1.5; 2.0) 1.6 (1.0; 1.8)⁎⁎ 1.8 (1.7; 2.2) 2.0 (1.5; 2.1)
HDL (mmol/l) 0.9 (0.9; 1.0) 0.9 (0.8; 1.0) 0.9 (0.8; 1.1) 1.0 (0.9; 1.2)
TAG (mmol/l) 1.3 (1.0; 2.0) 1.2 (0.9; 1.6)⁎⁎ 1.3 (1.0; 1.6) 1.2 (1.0; 2.0)
oxLDL (U/l) 106.7 (74.5; 149.3) 82.8 (57.6; 146.8) 120.8 (73.7; 141.2) 123.2 (90.9; 142.3)
oxLDL/LDL ratio 59.9 (43.4; 73.2) 63.0 (46.1; 80.3) 54.4 (41.7; 72.3) 67.3 (50.9; 78.1)
hsCPR (mg/l) 1.34 (0.63; 4.71) 0.94 (0.60; 1.69)⁎⁎ 1.76 (1.16; 3.25) 1.12 (0.75; 4.90)
IL-6 (ng/l) 4.0 (2.3; 5.9) 3.1 (2.4; 6.3) 5.4 (3.6; 9.3) 4.4 (3.1; 7.9)
Leucocytes (×109/l) 7.3 (6.3; 9.0) 7.1 (6.1; 8.8)⁎ 7.9 (6.6; 9.8) 7.9 (6.1; 8.9)
Neutrophils (×109/l) 4.4 (3.5; 5.4) 3.7 (3.2; 4.8)⁎ 4.8 (3.5; 6.3) 4.7 (3.8; 5.3)
All values are presented as medians with 1st and 3rd quartile in parenthesis.
BP— blood pressure, HR— heart rate, BMI— bodymass index, LDL— low density lipoprotein, HDL— high density lipoprotein, TAG— triglycerides, oxLDL— oxidized low density lipopro-
tein, hsCRP — high sensitivity C reactive protein, IL-6— interleukin 6.
⁎ p b 0.05 both when compared to the parameter before CR.
⁎⁎ p ≤ 0.01 both when compared to the parameter before CR.
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wards increment in nonsmoking control group (Tables 2A and 2B,
Fig. 3). While no signiﬁcant changes in IL-6 were observed during inter-
vention in all subgroups of patients (Fig. 2), smokers presented with a
higher concentration of IL-6 in the diet (signiﬁcant) group and in the
control group (nonsigniﬁcant) when compared to nonsmokers
(Table 2A and 2B).Table 2A
Comparison of inﬂammatory markers and oxLDL before and after CR between smokers and no
Non-smoking diets Smoking diet
Before CR After CR Before CR
hsCPR (mg/l) 1.10 (0.48; 1.39) 0.76 (0.42; 0.95)⁎ 4.05 (1.13
IL-6 (ng/l) 2.6 (2.1; 4.1) 2.6 (2.4; 4.4) 5.1 (3.3;
Leucocytes (×109/l) 6.9 (5.7; 7.3) 6.1 (5.1; 6.8)⁎ 8.7 (7.4;
Neutrophils (×109/l) 3.7 (3.2; 4.3) 3.2 (2.7; 3.8)⁎⁎ 5.2 (4.4;
oxLDL (U/l) 86.7 (69.7; 131.7) 75.1 (54.3; 84.2)⁎ 124.5 (77.9
oxLDL/LDL ratio 57.1 (40.8; 73.0) 54.4 (43.4; 75.4) 61.3 (45.8
Max. systolic BP
(mm Hg)
176 (157; 204) 184 (179; 209) 167 (159;
Max. HR (bpm) 113 (98; 122) 121 (109; 138)⁎ 116 (106;
Double product
(mm Hg ∗ bpm)
20,408 (14,695; 24,018) 24,028 (19,094; 27,308)⁎ 20,230 (16,9
Max. load (W) 111 (99; 153) 133 (114; 180)⁎ 112 (75; 1
Max. load (MET) 5.7 (4.8; 6.4) 6.7 (5.6; 7.3)⁎ 5.0 (3.2;
Time of load (min) 12.5 (10.8; 13.5) 13.5 (11.8; 17.3) 10.0 (8.0;
All values are presented asmedianswith 1st and 3rd quartile in parenthesis; all when compared
6, oxLDL— oxidized low density lipoprotein, BP— blood pressure, HR— heart rate.
⁎ p b 0.05.
⁎⁎ p ≤ 0.01.
# p ≤ 0.09.3.3. Correlations
Correlations between hsCRP, IL-6 and oxLDL, other inﬂammatory
markers, classic risk factors and exercise testing parameters in the
whole group of patients before and after CR are presented in the Table 3.
In complete group of patients hsCRP is the parameter which corre-
lated with the most other inﬂammatory markers (leucocytes,n-smokers in the diet group of patients.
s Diets: smokers vs.
nonsmokers before CR
Diets: smokers vs.
nonsmokers after CR
After CR Sig. Sig.
; 6.79) 1.56 (0.71; 3.32)# 0.013 0.006
9.2) 5.5 (2.9; 8.2) 0.016 NS (0.079)
11.2) 7.1 (7.8; 10.4) 0.004 0.000
6.2) 4.6 (3.6; 6.1) 0.013 0.001
; 150.2) 130.4 (56.7;150.9) NS (0.197) NS (0.085)
; 74.0) 68.6 (55.8; 88.0) NS NS
197) 188 (150; 210) NS NS
128) 119 (105; 121) NS NS
60; 24,426) 22,372 (20,760; 25,410) NS NS
25) 120 (84; 150)⁎ NS NS
5.8) 4.9 (4.3; 6.4)⁎ NS NS (0.051)
12.0) 11.0 (10.0; 13.0) 0.029 NS (0.072)
to the parameter before CR; hsCRP— high sensitivity C reactive protein, IL-6— interleukin
Table 2B
Comparison of inﬂammatory markers and oxLDL before and after CR between smokers and non-smokers in the control group of patients.
Non-smoking
controls
Smoking
controls
Controls: smokers vs.
nonsmokers before CR
Controls: smokers vs.
nonsmokers after CR
Before CR After CR Before CR After CR Sig. Sig.
hsCPR (mg/l) 1.76 (1.12; 3.39) 1.10 (0.51; 2.42) 2.18 (1.12; 3.31) 1.35 (0.80; 5.62) NS NS
IL-6 (ng/l) 4.8 (3.6; 9.6) 3.4 (3.0; 8.0) 7.3 (3.4; 9.3) 5.5 (3.6; 8.0) NS NS
Leucocytes (×109/l) 6.1 (5.8; 7.7) 6.3 (5.8; 7.9) 9.2 (8.0; 10.6) 8.5 (8.0; 9.1) 0.003 0.015
Neutrophils (×109/l) 3.9 (3.4; 5.1) 3.9 (3.0; 5.2) 5.7 (4.3; 7.1) 4.8 (4.5; 5.8) 0.023 0.029
oxLDL (U/l) 97.5 (66.0; 134.8) 123.2 (92.0; 142.4)# 126.8 (86.3; 157.7) 123.9 (77.6; 142.5) NS NS
oxLDL/LDL ratio 44.3 (32.9; 59.6) 58.2 (44.7; 67.8) 63.5 (51.7; 81.5) 74.8 (52.5; 80.2) 0.043 NS (0.095)
Max. systolic BP
(mm Hg)
165 (160; 207) 197 (171; 213)⁎ 170 (153; 200) 184 (170; 200) NS NS
Max. HR (bpm) 107 (92; 112) 113 (101; 127)⁎ 118 (110; 120) 123 (114; 132)# NS (0.063) NS
Double product
(mm Hg ∗ bpm)
17,970 (14,080; 24,231) 23,478 (17,385; 26,911)⁎ 19,078 (15,257; 23,702) 22,489 (19,816; 26,669)⁎ NS NS
Max. load (W) 101 (79; 121) 103 (100; 134)⁎ 100 (84; 120) 114 (93; 150)⁎ NS NS
Max. load (MET) 5.5 (4.6; 6.0) 5.9 (5.4; 7.0)⁎ 5.1 (4.5; 6.7) 5.6 (5.4; 6.2)⁎ NS NS
Time of load (min) 9.5 (9.0; 13.5) 12.0 (10.8; 14.3)⁎ 11.0 (9.0; 12.3) 13.0 (10.0; 14.0)⁎ NS NS
All values are presented asmedianswith 1st and 3rd quartile in parenthesis; all when compared to the parameter before CR; hsCRP— high sensitivity C reactive protein, IL-6— interleukin
6, oxLDL— oxidized low density lipoprotein, BP— blood pressure, HR— heart rate.
⁎ p b 0.05.
# p ≤ 0.09.
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oxLDL,which correlateswith the least of inﬂammatorymarkers but cor-
relates with blood lipids (Table 3). Whenwe calculated the correlations
of patients' subgroups (smokers and nonsmokers) we indeed found
similar but less signiﬁcant correlations (probably due to low number
of patients and high variability of parameters) as in the complete
group of patients (data not shown). Regarding correlations withFig. 1. Comparison of hsCRP in smokers and non-smokers before and aparameters of exercise capacity we found in the complete group of
patients signiﬁcant negative correlations between hsCRP, IL-6 and
parameters of exercise capacity (Table 3). In smoker subgroup hsCRP
before CR correlated negatively with maximal load before CR (p =
0.043, r = −0.445) and with maximal load after CR (p = 0.007,
r =−0.573), hsCRP after CR correlated negatively with max. load be-
fore CR (p = 0.025, r =−0.488). No similar correlations were foundfter CR in the diet group (a) and the control (b) group of patients.
Fig. 2. Comparison IL-6 in smokers and nonsmokers before and after CR in the diet group (a) and the control (b) group of patients.
45P. Mlakar et al. / IJC Heart & Vasculature 7 (2015) 40–48in nonsmokers. In nonsmokers oxLDL after CR negatively correlated
with double product before CR (p= 0.030, r =−0.498) andwith dou-
ble product after CR (p = 0.031, r =−0.496). No similar correlations
were found in smokers.Fig. 3. Comparison ox-LDL in smokers and nonsmokers before and aft4. Discussion
The results of our study show that relatively short (two week long)
CR program for patients suffering from AMI effectively ander CR in the diet group (a) and the control (b) group of patients.
Table 3
Correlations between inﬂammatory markers, classic risk factors and exercise testing parameters in whole group of patients before and after CR.
hsCRP (mg/l) IL-6 (ng/l) oxLDL (U/l)
Before CR After CR Before CR After CR Before CR After CR
Leucocytes (×109/l) Before CR 0.440⁎⁎ 0.428⁎⁎ 0.422⁎⁎ NS NS NS
After CR 0.346⁎ 0.543⁎⁎⁎ 0.388⁎ NS NS NS
Neutrophils (×109/l) Before CR 0.496⁎⁎⁎ 0.423⁎⁎ 0.491⁎⁎⁎ NS NS NS
After CR 0.346⁎⁎ 0.591⁎⁎⁎ 0.517⁎⁎⁎ NS NS NS
Lymphocites (×109/l) Before CR NS NS NS NS NS NS
After CR NS NS NS NS NS NS
hsCRP (mg/l) Before CR / 0.348⁎ 0.549⁎⁎⁎ NS 0.341⁎ 0.302#
After CR 0.348⁎ / 0.388⁎ 0.310# NS NS
IL-6 (ng/l) Before CR 0.549⁎⁎⁎ 0.388⁎ / NS 0.352⁎ 0.350⁎
After CR NS NS NS / NS NS
oxLDL (U/l) Before CR 0.341⁎ NS 0.352⁎ NS / 0.643⁎⁎⁎
After CR 0.302# NS 0.350⁎ NS 0.643⁎⁎⁎ /
Total cholesterol (mmol/l) Before CR 0.307# NS 0.329⁎ NS 0.516⁎⁎⁎ 0.527⁎⁎⁎
After CR 0.301# NS 0.306# NS 0.461⁎⁎ 0.725⁎⁎⁎
LDL (mmol/l) Before CR 0.376⁎ NS 0.398⁎⁎ NS 0.598⁎⁎⁎ 0.576⁎⁎⁎
After CR 0.331⁎ NS 0.343⁎ NS 0.516⁎⁎⁎ 0.721⁎⁎⁎
BMI (kg/m2) Before CR 0.363⁎ NS NS NS NS NS
After CR 0.371⁎ NS NS NS NS NS
Resting HR (bpm) Before CR 0.286# NS NS NS NS NS
After CR 0.397⁎⁎ 0.350⁎ 0.448⁎⁎ NS 0.329⁎ NS
Maximal systolic BP (mm Hg) Before CR NS NS NS −0.348⁎ NS NS
After CR NS NS NS −0.441⁎⁎ NS NS
Maximal load (MET) Before CR −0.325⁎ NS NS −0.334⁎ NS NS
After CR −0.358⁎ NS NS NS NS NS
Maximal load (W) Before CR NS −0.412⁎⁎ NS −0.326⁎ NS NS
After CR −0.273# −0.364⁎ NS NS NS NS
Double product Before CR NS NS NS −0.382⁎ NS NS
After CR NS NS NS −0.420⁎⁎ NS NS
Time of load (min) Before CR NS −0.333⁎ NS −0.407⁎ NS NS
After CR NS −0.347⁎ NS NS NS NS
All values are presented as correlation coefﬁcient; hsCRP— high sensitivity C reactive protein, IL-6— interleukin 6, oxLDL— oxidized lowdensity lipoprotein, BMI— bodymass index, HR—
heart rate, BP— blood pressure.
⁎ p b 0.05.
⁎⁎ p ≤ 0.01.
⁎⁎⁎ p ≤ 0.001.
# p ≤ 0.09
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modiﬁes classic risk factors and also beneﬁcially interferes with the
pathological processes of the underlying disease— atherosclerosis. It di-
minishes observedmarkers of chronic inﬂammation and reduces oxida-
tive modiﬁcation of LDL. However, these positive consequences, as well
as signiﬁcant decline in oxLDL, become pronounced only if we add a su-
pervised, balanced cardioprotective diet rich with natural antioxidants
to the CR program and if the patient does not smoke. Thus we could
extrapolate that the addition of diet importantly ampliﬁes the beneﬁcial
effects of exercise training on both inﬂammation and oxidized LDL
already in relatively short (two week long) CR program in patients
suffering from AMI.
It has already been shown that coupled physical activity and diet
lead to positive consequences in patients with metabolic syndrome;
they not only improve lipid and metabolic proﬁle, but also diminish in-
ﬂammation and oxidative stress and therefore stabilize lipid plaques
[20]. Firstly, as expected, our two week CR program, which includes su-
pervised physical activity and counseling about healthy diet, improved
parameters of exercise testing. Improvement of classic risk factors, in-
ﬂammatorymarkers and oxLDL levels on the other handwas not signif-
icant in the control group of patients, without a supervised diet. Many
studies emphasize the importance of a cardioprotective diet as a non-
pharmacological measure in secondary prevention of coronary heart
disease [27,28]. Contrary to the control group of patients, we observed
noteworthy beneﬁts of diet intervention: reduction of classic risk fac-
tors, including markers of metabolic syndrome (BMI, waist to hip
ratio, LDL, TAG, blood glucose, systolic blood pressure), and reduction
of inﬂammatory marker levels (leucocytes, neutrophils, hsCRP). It hasbeen known that dietary regimens decrease concentration of inﬂamma-
tory markers such as hsCRP, IL-6, white blood cell count and homocys-
teine in healthy adults [29] and patients with metabolic syndrome
[18], but very few studies described the effect of such diets in patients
with fully developed CAD [17]. Our cardioprotective diet, with the addi-
tion of walnuts and apples rich in antioxidants, already proved to be ef-
fective in a very short time period (2 weeks) in patients after AMI
undergoing CR. Thus, cardioprotective diet should become an obligatory
part of regular CRprograms in health resorts and a strong recommenda-
tion for secondary prevention of CAD not only in Slovenia but also in
other countries.
Our diet group consisted of signiﬁcantly younger patients than the
control group, which might be a source of bias in our results. It is
known that higher age is associated with higher levels of inﬂammatory
and oxidative stress markers [30–32], but we must keep in mind that
no differences in risk factors, inﬂammatory markers or oxLDL were
proved at the starting point of our study. Additionally, most of the studies
describing the differences in inﬂammatory and oxidative stress proﬁle be-
tween young people and adults studied groups with a much larger age
difference than demonstrated in our study, as our patients from both
the control group and the diet group belong to a group of middle aged
adults. On the other hand, we believe that patients from the diet group
had more severe disease, since they had no signiﬁcant differences in
risk factors than patients from the control group at the inclusion to the
study, but suffered from AMI at a younger age. These patients were also
highlymotivated to participate in the diet intervention,which attested ef-
fective. Thus, cardioprotective diet should be advised to all patients after
AMI, especially to younger patients with early atherosclerosis.
47P. Mlakar et al. / IJC Heart & Vasculature 7 (2015) 40–48When trying to interpret the lack of inﬂuence of the diet on oxLDL
levels and IL-6, we searched for the presence of confounding factors
that could have affected our results. It is known that smokers have ele-
vated levels of oxLDL [33,34], as cigarette smoke contains large amounts
of oxidants and free radicals, which promote oxidative modiﬁcation of
lipids and proteins [35,36]. Moreover, Hovolet and coworkers demon-
strated that current smoking presents one of the strongest risk factor
correlates of oxLDL [37]. Only a few studies have mentioned the inﬂu-
ence of smoking on IL-6 and have shown that apparently healthy
smoking man may have signiﬁcantly higher IL-6 levels than nonsmok-
ing man [38]. Therefore, we divided patients into smokers and non-
smokers in both the diet group and the control group of patients. We
are aware of the difﬁculty to interpret our results, since some signiﬁcant
associations might be found only by chance, due to measurements of
large number of variables in small groups of patients, yet we found
some truly interesting results. We observed that nonsmokers in the
diet group of patients altogether gained the most beneﬁts from CR:
we observed signiﬁcant decline in inﬂammatory markers (hsCRP,
leucocytes, neutrophils) except IL-6 and signiﬁcant decline in oxLDL
during CR. Thus, positive results of the entire diet group can be regarded
mainly to nonsmokers, while we could observe only a trend towards
hsCRP decline in smokers from the diet group. Effect of CR was rather
similar in smokers and nonsmokers from the control group. This result
could imply the importance of diet intervention during CR and smoking
cessation before CR to reach the optimal results regarding both inﬂam-
matory markers and oxLDL. The two week period of rehabilitation is
probably too short to annotate the lack of improvement of certain in-
ﬂammatory and oxidativemarkers in smokers only to higher compliance
of nonsmokers. It might be that smokers, due to already known higher
baseline level of oxidative stress and inﬂammation [33,34,39,40], need
longer periods of time than nonsmokers to reach the level, where thede-
sired effects become clinically shown. Since physical activity and diet
may have synergistic effects, it is possible that smokers, who usually
present with lower exercise capacity, were therefore less able to exert
the beneﬁcial effects of coupled diet and exercise program. Our study
did not demonstrate lower exercise capacity of smokers, but a study per-
formed by Hoad and Clay showed impeded performance adaption of
British Army Ofﬁcer cadets, who were smokers. Performance improve-
ment in 6 month training program proved to be signiﬁcantly greater in
nonsmokers [41]. The underlying mechanisms induced by smoking
that mediate impaired adaption to training remain unclear, but several
mechanisms such as oxidative stress, inﬂammation and circulatory
hormone levels have been suggested [42–44]. To add up, we anticipate
even better results if patients would have been included in long term su-
pervision after CR, since 2 week rehabilitation program is unfortunately
too short for patients to adopt major long term lifestyle changes.
When we calculated correlations, we observedmany positive corre-
lations between hsCRP and other inﬂammatory markers and between
hsCRP, IL-6 and oxLDL before CR. OxLDL positively correlated with
hsCRP before CR, which is a known fact. Data from the literature even
suggest that elevated levels of oxLDL and hsCRP may serve as markers
of the severity of coronary artery disease and are related to classical
risk factors such as dyslipidemia, obesity and smoking, what was simi-
larly demonstrated also in our study [37,45]. Furthermore, we observed
that oxLDL positively correlated with IL-6 before CR, which is in accor-
dance with a previous research, which showed clear correlation and
also predictive value of IL-6 and oxLDL in development of mobility lim-
itations in older adults [46]. We discovered that in our complete group
of patients, the ones with higher hsCRP presented with lower physical
ﬁtness and gained less physical capacity during CR (negative correla-
tions with maximal load before and after CR). Similarly the oxLDL neg-
atively correlated with double product in nonsmokers after CR, which
also implicates that higher oxidative stress presents an impediment
for exercise capacity gain. Themost interesting result regarding correla-
tions between hsCRP, IL-6 and oxLDL was that signiﬁcant correlations
between them demonstrated before CR in the complete group ofpatients, which were related to lipids and obesity, disappeared after
CR. This result further supports our observations that CR has a diverse
impact on inﬂammatory and oxidative stress markers in different sub-
groups of patients (diet/controls, smokers/nonsmokers). Subsequent
trials studying relationships between oxidative stress and inﬂammatory
markers are necessary.
To sum up, our results indicate the importance of diet intervention
during CR program. Furthermore, diet positively modiﬁes the inﬂam-
matory state and oxLDL mainly in nonsmokers. Smoking showed to be
an important unfavorable confounding factor regarding the improve-
ment of exercise capacity, reduction of oxLDL and inﬂammatory
markers. Thus, it is crucial that patients stop smoking before entering
the CR program and that diet intervention becomes an integral part of
every CR program for patients after AMI. Positive effects of CR might
be only transient if patients discontinue to eat healthy, be physically ac-
tive and start smoking again when coming home from CR program. For
long-term beneﬁt of CR program it would be crucial, if patients had
support from special associations and also health system, which
would enable them to continue with healthy lifestyle.5. Limitations
This study was an interventional, non-randomized, pilot study on
a rather small number of patients and therefore some expected dif-
ferences between groups might not be signiﬁcant only due to this
fact. On the contrary, some observed signiﬁcant differences and cor-
relations might be result of measuring several parameters in groups
with small number of patients. Further, the results of the study re-
garding control group of patients might be partly subject to sponta-
neous disease processes after AMI including reduction markers of
inﬂammation and oxLDL, since we did not include a group of patients
with no CR during the same period of time, what we thought would
not be ethical. The diet group proved to be signiﬁcantly younger than
the control group, which could result in biased results, however no
signiﬁcant differences in classical risk factors, inﬂammation markers
or oxLDL existed at the start of the CR. Multiple other confounding
factors besides smoking, such as motivation and compliance, which
might be lower in smokers and could also inﬂuence the outcome of
the CR, were not studied.Disclosure statement
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